Nash, A.
Gijsen, H. J. M.
Hrupka, B. J.
Teng, K. S.-L.
Lichtenthaler, S. F.
Takeshima, H.
Gunnersen, J. M.
Munro, K. M.
Funding for this research was provided by:
Australian Government Research Training Program
Australian National Health and Medical Research Council (Project Grant 10008046)
Deutsche Forschungsgemeinschaft (Munich Cluster for Systems Neurology (EXC 2145 SyNergy, project ID 390857198))
Universities Australia (UA)-Deutsche Akademischer Austauschdienst (Research Co-operation Grants)
National Health and Medical Research Council - Australian Research Council Dementia Research Development Fellowship
Article History
Received: 6 April 2021
Accepted: 7 July 2021
First Online: 23 July 2021
Competing interests
: Harrie Gijsen and Brian Hrupka are employees of Janssen Pharmaceutica NV and Harrie Gijsen holds stock of Johnson & Johnson. All other authors declare they have no competing interests.